June 5, 2019
The opioid manufacturer Insys Therapeutics agreed to pay $225 million to settle federal criminal and civil charges that it illegally marketed a highly addictive fentanyl painkiller to doctors, federal prosecutors said on Wednesday.
Insys, the Opioid Drug Maker, to Pay $225 Million to Settle Fraud Charges
Comments